Randomized Comparison of Three Endoscopic Gastroplasty Techniques for Treating Obesity in Adults
Led by Mater Olbia Hospital · Updated on 2025-02-03
189
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating three different Endoscopic Gastroplasty EG techniques for treating obesity in adults with a body mass index BMI between 30 and 44.99 kgm2. This study aims to compare the safety and effectiveness of these minimally invasive procedures, which reduce stomach capacity and alter gastric motility, over an 18-month period. The trial is conducted at a single center and involves a multidisciplinary team to assess patients before and after treatment.
Participants will be randomly assigned to one of three EG procedures Endoscopic Sleeve Gastroplasty ESG using the Overstitch suturing device, Primary Obesity Surgery Endolumenal-2 POSE-2 with an overtube-style platform, or Endoluminal Vertical Gastroplasty EVG using a triangulation platform. These procedures are performed under general anesthesia by experienced endoscopists. After the procedure, patients receive tailored diets and follow-up care including psychological support and dietician visits at several time points up to 540 days post-treatment.
Throughout the study, patients will undergo regular assessments including anthropometric measurements, blood tests, liver ultrasounds with elastography, transit studies, and barium x-rays to monitor changes in weight, stomach size, and liver health. Researchers will evaluate weight loss outcomes such as total body weight loss and excess weight loss, safety through monitoring adverse events, and quality of life using validated questionnaires. The study includes a comprehensive follow-up schedule to support patient adherence and evaluate long-term effects.
CONDITIONS
Brief Title
Bariatric Endoscopy for Treatment of Obesity
Research Team
S
Salvatore F. Vadalà di Prampero, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Willingness to provide written informed consent for endoscopic gastroplasty
Ability to understand and follow the study protocol
Obesity with BMI 30-34.99 kg/m2 with previous failed diets and obesity-related diseases
Obesity with BMI 35-39.99 kg/m2 with previous failed diets, with or without obesity-related diseases
Obesity with BMI 40-44.99 kg/m2 with previous failed diets, with or without obesity-related diseases, and not fit for surgery
You will not qualify if you...
Lack of consent or inability to provide consent
Conditions preventing compliance with study instructions
Previous surgical or endoscopic bariatric treatments
Allergies or intolerance to study medications
Women who are pregnant, nursing, or of child-bearing potential not using contraception
Life-threatening medical conditions
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (in-person)
Treatment
Duration - Single procedure with immediate post-procedure care
Participants undergo one of three endoscopic gastroplasty procedures to reduce stomach capacity and alter gastric motility as a treatment for obesity.
1 procedure visit (in-person) with anesthesia and monitoring
Follow-up
Duration - Up to 18 months
Participants attend regular follow-up visits with dietician, psychological, and gastroenterological assessments to monitor weight loss, behavior changes, quality of life, and any adverse effects.
Five follow-up visits at approximately 1, 3, 6, 12, and 18 months after the procedure (in-person)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Virtual Nutrition Education to Prevent Weight Gain During Maintenance Chemotherapy in Children and Adolescents with Acute Lymphoblastic Leukemia
Study of Gene Expression in Tissues Related to Blood Sugar and Weight in Adults Undergoing Abdominal Surgery
Phase 1 Study of Single-Dose Semaglutide Nasal Spray to Assess Safety, Tolerability, and Pharmacokinetics in Adults with Overweight or Obesity Aged 18 to 65
Evaluating Multimodal Ultrasound to Monitor Muscle Mass in Metabolic Syndrome, Type 2 Diabetes, and Obesity
Reducing Obesity and Related Health Risks in Native American Employees at Twin Arrows Casino Using a Culturally Relevant Plant-Rich Diet
Study of Safety, Tolerability, and Effects of NNC0721-8060 Compared to Semaglutide and Placebo in Adults with Overweight or Obesity
Phase 12a Study Evaluating Safety and Effects of ARO-ALK7 in Adults With Obesity, With or Without Type 2 Diabetes
Master Protocol Evaluating Multiple Investigational Treatments for Chronic Weight Management in Adults with Obesity or Overweight
Evaluating a Digital Tool to Help Clinicians Prescribe Personalized Exercise for Adults with Cardiovascular Disease Risk Factors in a Randomized Crossover Trial
Testing a Responsive Parenting Program to Prevent Obesity in High-Risk Infants Through Pediatric Primary Care
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The Impact of Different Surgical Techniques on Outcomes in Laparoscopic Sleeve Gastrectomies: The First Report from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP).
Elizabeth R Berger, Ronald H Clements, John M Morton...